Rio Tinto Posts Strong Q4 Iron Ore and Copper Output on Operational Recovery 
SoftBank Shares Surge as AI Optimism Lifts Asian Tech Stocks 
FSU Criticizes ANZ Over Suncorp Bank Job Cuts Amid Post-Acquisition Commitments 
Baidu Shares Surge After Official Launch of Advanced Ernie 5.0 AI Model 
FAA Says It Is Not Blocking Boeing 737 MAX 7 and MAX 10 Certification 
Valero Makes First Venezuelan Crude Purchase Under New U.S.-Caracas Deal 
Walmart to Cut PhonePe Stake in IPO as Tiger Global and Microsoft Exit 
OpenAI Launches Stargate Community Plan to Offset Energy Costs and Support Local Power Infrastructure 
Court Allows Expert Testimony Linking Johnson & Johnson Talc Products to Ovarian Cancer 
Pop Mart Shares Surge in Hong Kong After First Buyback in Nearly Two Years 
Trump Signs Executive Order to Limit Wall Street Investment in Single-Family Homes 
Global DRAM Chip Shortage Puts Automakers Under New Cost and Supply Pressure 
JPMorgan and Allen & Company Emerge as Big Winners in Warner Bros Discovery Bidding War 
Apple Stock Jumps as Company Prepares Major Siri AI Chatbot Upgrade 
Morgan Stanley Flags High Volatility Ahead for Tesla Stock on Robotaxi and AI Updates 
Memory Chip Shortage Drives Higher Gadget Prices and Weakens Global Tech Demand 
MALVERN, Pa., May 01, 2017 -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a clinical-stage dermatologist-led biotechnology company, today announced that members of its management team will present and host investor meetings at the following upcoming investor events:
- Management will host investor meetings during the William Blair Late Stage Conference in New York, NY on Wednesday, May 10, 2017.
- Management will host investor meetings during the Bank of America Merrill Lynch 2017 Healthcare Conference in Las Vegas, NV on Wednesday and Thursday, May 17 and 18, 2017.
- Dr. Neal Walker, President and Chief Executive Officer, will present at Jefferies Global Healthcare Conference in New York, NY on Thursday, June 8, 2017 at 3:30 PM EDT.
- Dr. Walker will also present at William Blair Growth Stock Conference in Chicago, IL, on Tuesday, June 13, 2017 at 7:30 AM CDT.
- Management will host investor meetings during the JMP Securities Life Sciences Conference in New York, NY on Tuesday, June 20, 2017.
A live webcast of the Jefferies Global Healthcare Conference and the William Blair Growth Stock Conference presentations may be accessed through the Company's web site, www.aclaristx.com, on the 'Events and Presentations' section. An archived version of the presentation will be available for 30 days.
About Aclaris Therapeutics, Inc.
Aclaris Therapeutics, Inc. is a clinical-stage dermatologist-led biotechnology company focused on identifying, developing and commercializing innovative and differentiated therapies to address significant unmet needs in medical and aesthetic dermatology. Aclaris is based in Malvern, Pennsylvania and more information can be found by visiting the Aclaris website at www.aclaristx.com.
Contact: Aclaris Contact Michael Tung, M.D. Vice President / Investor Relations 484-329-2140 [email protected] Media Contact Mariann Caprino TogoRun 917-242-1087 [email protected]
